Although this study screened core active compounds and targets for AP through network pharmacology and validated the therapeutic effect of linarin on AP as well as the involvement of the PI3K/AKT pathway through in vivo and in vitro experiments, there are still certain limitations. This evidence concerns the gene AKT1 and alkaline phosphatase measurement.